Hyperfine (HYPR, Financial) has begun enrolling patients in its pioneering NEURO PMR study, a first-of-its-kind multi-center, prospective observational research project. This study is set to compare portable ultra-low-field MRI technology with traditional high-field MRI regarding pathology findings, clinical utility, and patient experience.
The NEURO PMR study is being conducted in collaboration with two leading private neurology institutes, the DENT Neurologic Institute and Texas Neurology. The study features the use of the latest AI-powered portable MRI technology that promises advanced image quality.
The primary aim of the study is to assess the applicability of portable brain MRI technology within comprehensive neurology practices, making advanced imaging more accessible and cost-effective. The target is to enroll 100 participants, with the study expected to reach completion by the end of the year.
According to Dr. Laszlo Mechtler, the study's Principal Investigator and Chief Medical Officer at the DENT Neurologic Institute, neuroimaging is now a fundamental component of modern neurological care, with neurologists commonly ordering numerous MRIs annually. However, in-office imaging capabilities are often unavailable in private practices. This study seeks to bridge this gap, enhancing access to diagnostic tools for patients and healthcare providers alike.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for Hyperfine Inc (HYPR, Financial) is $1.30 with a high estimate of $1.50 and a low estimate of $1.20. The average target implies an upside of 85.86% from the current price of $0.70. More detailed estimate data can be found on the Hyperfine Inc (HYPR) Forecast page.
Based on the consensus recommendation from 4 brokerage firms, Hyperfine Inc's (HYPR, Financial) average brokerage recommendation is currently 2.5, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Hyperfine Inc (HYPR, Financial) in one year is $2.55, suggesting a upside of 265.28% from the current price of $0.698099. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Hyperfine Inc (HYPR) Summary page.
